PURUSHOTTAM V PANDE
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology GULFPORT, MS NPI 1619953072
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology MS PharmaEssentia USA Corporation All categories
General Payments — all program years on this page
$4,093.38
- Category: General Payments
- Program years: PY2018–2024
- Record count: 234
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $751.04 across 35 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $751.04 | 35 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PharmaEssentia USA Corporation | $85.59 | 3 |
| Acerta Pharma LLC | $75.58 | 4 |
| Incyte Corporation | $70.36 | 3 |
| Merck Sharp & Dohme Corporation | $64.54 | 3 |
| Genentech USA, Inc. | $54.03 | 2 |
| Daiichi Sankyo Inc. | $42.74 | 2 |
| ABBVIE INC. | $38.15 | 2 |
| PUMA BIOTECHNOLOGY, INC. | $33.67 | 2 |
| EISAI INC. | $30.72 | 1 |
| JAZZ PHARMACEUTICALS INC. | $29.45 | 1 |
| Regeneron Healthcare Solutions, Inc. | $24.33 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.54 | 1 |
| Exelixis Inc. | $21.06 | 1 |
| GENZYME CORPORATION | $20.28 | 1 |
| SOBI, INC | $20.25 | 1 |
| ARRAY BIOPHARMA INC | $19.46 | 1 |
| Karyopharm Therapeutics Inc. | $17.73 | 1 |
| Janssen Biotech, Inc. | $17.50 | 1 |
| Genmab U.S., Inc. | $17.29 | 1 |
| Lilly USA, LLC | $15.93 | 1 |
| Alexion Pharmaceuticals, Inc. | $15.67 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.17 | 1 |
By program year
Records — PY2024 (35)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.